Table 3 Optical coherence tomography (OCT) features at the time of identification of CPHF:
From: Central posterior hyaloid fibrosis: evolution and outcomes
Variable | Value |
|---|---|
No. of eyes (n) | 32 |
Type 2 MNV (n, %) | 32 (100) |
Mean visual acuity (logMAR), Snellen equivalent | 1.498 ± 0.374 (20/630) |
Subfoveal location of MNV (n, %) | 32 (100) |
Absent fluid (n, %) | 22 (69) |
Presence of SRF (n, %) | 6 (19) |
Presence of IRF (n, %) | 10 (31) |
Presence of SHRM (n, %) | 0 (0) |
Presence of hard exudates (n, %) | 1 (3) |
Presence of hemorrhage (n, %) | 1 (3) |
Presence of RPE tear | 2 (6) |
Absence of posterior hyaloid detachment at the fovea | 32 (100) |
Presence of ERM at the fovea | 13 (41) |
No. of eyes treated with intravitreal anti-VEGF injections after the identification of CPHF | 10 (31) |
Mean ± SD number of injections given in these eyes after the identification of CPHF (Range) | 0.89 ± 1.367 (1–6) |